U.N. official calls for moratorium on artificial intelligence tools that breach human rights
By Sammy Westfall,
The Washington Post
| 09. 15. 2021
The rapid evolution of artificial-intelligence-based technologies and their adoption by businesses and governments have outpaced efforts to hold them to human rights standards, Michelle Bachelet, the United Nations Commissioner for Human Rights, warned Wednesday.
She called for a moratorium on artificial intelligence systems that could put human rights at risk — at least until stronger safeguards are in place internationally.
“We cannot afford to continue playing catch-up regarding AI — allowing its use with limited or no boundaries or oversight, and dealing with the almost inevitable human rights consequences after the fact,” she said in a statement.
The remarks came alongside the publication of a report by the U.N. Human Rights Council analyzing the human rights risks posed by a range of AI-powered technologies — including profiling, automated decision-making and machine learning. The consequences of unfettered proliferation of such technologies could be “catastrophic,” Bachelet said.
The report also pointed out that data sets used by AI can have historical racial and ethnic biases embedded, which can perpetuate, or enhance, discrimination.
Many AI tools seek to predict outcomes, assess risk and...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...